No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

Detalles Bibliográficos
Autores principales: Molina, J.M., Delaugerre, C., Le Goff, J., Mela-Lima, B., Ponscarme, D., Goldwirt, L., de Castro, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195369/
https://www.ncbi.nlm.nih.gov/pubmed/32240719
http://dx.doi.org/10.1016/j.medmal.2020.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195369/
https://www.ncbi.nlm.nih.gov/pubmed/32240719
http://dx.doi.org/10.1016/j.medmal.2020.03.006

Ejemplares similares